Skip to main content

Table 3 HUVEC Nanostring: IPA® upstream regulator analysis predicted that endotoxin, cytokine, and TLR signaling regulators are inhibited by apabetalone

From: Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

IPA upstream regulators

Ingenuity® Pathway Analysis

Target

z-score

TNFα

Apabetalone

5 μM

Apabetalone

20 μM

Endotoxin

LPS

6.3

− 3.3

− 4.4

Cytokines

TNFα

6.1

− 2.6

− 4.2

NF-κB (complex)

5.9

− 2.7

− 3.5

IL-1β

5.4

− 1.9

− 3.3

IL-1α

4.9

− 2.2

− 1.8

RELA

4.8

− 1.9

− 2.7

IFNG

4.3

− 2.9

− 4.0

IL-6

2.6

− 1.6

− 1.5

TLR signaling

TLR4

5.3

− 3.3

− 4.4

TICAM1

5.1

− 2.7

− 4.5

MYD88

5.1

− 3.1

− 4.1

TLR3

5.0

− 3.3

− 3.5

  1. Positive activation z-scores reflect the predicted activation of an upstream regulator (significant when > ~ 2)
  2. Negative activation z-scores reflect the predicted inactivation of an upstream regulator (significant when < ~− 2)